{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:05:46Z","timestamp":1792253146761,"version":"4.4.0"},"reference-count":44,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Extracorporeal photopheresis is an immunomodulatory therapy indicated for patients with cutaneous T\u2010cell lymphoma, graft\u2010versus\u2010host disease, and heart or lung allograft rejection. Whole blood from the patient is drawn into the photopheresis instrument where it is separated into its components. Plasma, red blood cells, and the treated buffy coat are subsequently returned to the patient. Consistent, adequate blood flow is necessary to successfully complete the procedure. Vascular access options for photopheresis include peripheral vein cannulation, tunneled central venous catheters, and subcutaneous ports. Photopheresis is a very safe procedure; however, the complications and impact on the patient's quality of life associated with vascular access devices can be significant.<\/jats:p>","DOI":"10.1111\/trf.14500","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T14:12:01Z","timestamp":1518617521000},"page":"590-597","source":"Crossref","is-referenced-by-count":14,"title":["Vascular access considerations for extracorporeal photopheresis"],"prefix":"10.1111","volume":"58","author":[{"given":"Jill","family":"Adamski","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Phoenix Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-0502(02)00097-6"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702053160603"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2015.02.005"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21470_c"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12311"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21542"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.07.031"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.10.003"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.11.008"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00349"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09081.x"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21486"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.4065\/81.9.1159"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2009.00716.x"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21493"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21225"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.tvir.2011.05.008"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.tvir.2011.05.003"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.10.722"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir257"},{"key":"e_1_2_16_22_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.idc.2017.05.007","article-title":"Prevention of central line\u2010associated bloodstream infections","volume":"31","author":"Bell T","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.12.575"},{"key":"e_1_2_16_24_1","article-title":"How to perform extracorporeal photopheresis via port catheter","author":"Schwede K","year":"2017","journal-title":"Transfusion"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21393"},{"key":"e_1_2_16_26_1","unstructured":"RyanMJ.Approval letter: PowerFlow\u2122 implantable apheresis IV port. Silver Spring (MD): Food and Drug Administration; 2017 Apr 17 [cited2017Sep 21]. Available from:https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/K163001.pdf."},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20024"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2729.2001.00153.x"},{"key":"e_1_2_16_29_1","unstructured":"PowerFlow implantable apheresis IV port [Internet]. Tempe (AZ): Bard Peripheral Vascular Inc.;2017Apr 17 [cited 2017 Sep 12]. Available from:http:\/\/www.bardpv.com\/wp-content\/uploads\/2017\/05\/BPV-PRT3-1016-0002-1-v1.1-PowerFlow-Brochure.pdf."},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21267"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/421946"},{"key":"e_1_2_16_32_1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.tvir.2011.05.009","article-title":"Diagnosis and treatment of central venous access\u2010associated infections","volume":"14","author":"Meek ME.","year":"2011","journal-title":"Tech Vasc Interv Radiol"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01910507"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(98)70162-4"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.5301\/jva.5000538"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-693671"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.008"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.2.188"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.07.013"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.306"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12071"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0658"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2010.01.044"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S142556"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.76"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.14500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:34:10Z","timestamp":1694630050000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.14500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":44,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/trf.14500"],"URL":"https:\/\/doi.org\/10.1111\/trf.14500","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}